UCSF is trying a new tactic to eradicate long COVID symptoms. Hereâ€™s how it works
-----
Michael Dahl walked into a UCSF clinic in San Francisco the other day, as he has done many times since the brain-sapping symptoms of long COVID changed his life nearly two years ago.But this time, he and his doctors hoped it would be Dahl who will change long COVID.
On Aug. 22, Dahl became the first person to receive an infusion of monoclonal antibodies aimed at treating the confounding condition that has impaired millions of people around the world.
The clinical trial is one
